Creatine Decoded: ACD-Funded CTD Drug Repurposing Fellowships Make Progress in Year One
Patient Samples from Coriell Biobank in Studies Seeking to Understand CTD Mutations & Explore Existing FDA-Approved Drugs as Potential Treatments
#CreatineDecoded is a quarterly educational essay series that sheds light on research relevant for Cerebral Creatine Deficiency Syndromes (CCDS). The essays and interviews feature community contributors, often parents, who with the help of the ACD, explore in their own words the CCDS science you want to know more about.
Have a topic in mind? Send suggestions to Laura Trutoiu, ACD Director of Research email@example.com. Continue reading